RxDoctor Payments DataLook up a doctor →

Yun Sun, MD

Pain Medicine · Greensboro, NCNPI 1316913098

Payments from drug & device makers

$9,111in general payments, 2019–2025

Across 455 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$979
  • Collegium Pharmaceutical, Inc.$795
  • Amgen$782
  • Lilly USA, LLC$632
  • AstraZeneca$573
  • plus $4K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk83$1,385
AbbVie(2 entities)68$979
Collegium Pharmaceutical, Inc.44$795
Amgen19$782
Lilly USA, LLC38$632
AstraZeneca14$573
Forte Bio-pharma LLC10$339
Exact Sciences8$323
Pfizer16$322
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$301
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$184
Virtus Pharmaceuticals LLC9$181
Biohaven Pharmaceuticals, Inc.7$170
Otsuka America Pharmaceutical, Inc.5$117
Sanofi3$116
Indivior Inc.6$104
Takeda Pharmaceuticals U.S.A., Inc.6$100
Sentynl Therapeutics, Inc.7$100
Dexcom, Inc.3$99
Mylan Specialty L.p.4$97
Merck7$96
Amarin Pharma, Inc.5$86
Biohaven Pharmaceutical Holding Company Ltd.4$85
Ironwood Pharmaceuticals, Inc5$78
Bayer5$78
Corcept Therapeutics3$76
Genentech USA, Inc.5$76
Xeris Pharmaceuticals, Inc.4$75
Idorsia Pharmaceuticals US Inc4$72
Abbott3$61
Phathom Pharmaceuticals, Inc.3$53
Boehringer Ingelheim3$52
GSK3$51
Kowa Pharmaceuticals America, Inc.3$45
Supernus Pharmaceuticals, Inc.2$37
Viatris Specialty LLC1$32
Baxter Healthcare1$31
Antares Pharma, Inc.1$24
Scilex Pharmaceuticals Inc.1$24
Medtronic1$24
Esperion Therapeutics, Inc.1$21
Radius Health, Inc.1$21
Eisai Inc.1$21
GRT US Holding, Inc.1$20
Inspire Medical Systems, Inc.1$18
Vanda Pharmaceuticals Inc.1$17
Arbor Pharmaceuticals, Inc.1$17
Shield Therapeutics Inc1$16
Sanofi-aventis U.S. LLC1$16
Tonix Medicines, Inc.1$15
Sun Pharmaceutical Industries Inc.1$14
ANI Pharmaceuticals, Inc.1$14
Boston Scientific1$12
Teva Pharmaceuticals USA, Inc.1$12
Biodelivery Sciences International, Inc.1$12
Assertio Therapeutics, Inc.1$11

How this compares

$9,111 in reported general payments places this provider in the 70th percentile of 182 pain medicine providers in North Carolina.

See all pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$82,239
Medicare patients
122
Services billed
2,369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pain medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →